TrialPain2015

A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain.

Dan Ziegler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.